Table 3

Effect of adherence to the written action plan on exacerbation recovery time and unscheduled healthcare utilisation

Study definition* (n=217 exacerbations)AdherenceCrudeAdjusted
Yes (n=87)No (n=130)B/OR95% CIp ValueB/OR95% CIp Value
Exacerbation total recovery time, days10.9 (5.6)16.0 (10.7)−5.08−7.62 to −2.550.0001−5.84−8.44 to −3.230.0001
Treated recovery time, days10.5 (5.6)12.3 (9.0)−1.8−4.03 to 0.420.112−2.21−4.58 to 0.160.072
Unscheduled healthcare utilisation, yes§42 (49.4)65 (51.2)0.930.54 to 1.610.8010.940.49 to 1.830.864
Additional definition (n=217 exacerbations)Yes (n=87)No (n=130)
Exacerbation total recovery time, days11.2 (6.8)18.6 (11.1)−7.43−9.91 to −4.960.0001−7.36−9.85 to −4.870.0001
Treated recovery time, days10.7 (6.7)13.1 (9.3)−2.38−4.66 to 0.10.040−2.04−4.37 to 0.290.090
Unscheduled healthcare utilisation, yes§39 (50.6)65 (50.0)0.970.67 to 1.720.9280.990.52 to 1.960.978
Worst case analysis (n=288 exacerbations)Yes (n=87)No (n=201)
Exacerbation total recovery time, days10.9 (5.6)15.0 (10.2)−4.09−6.46 to −1.720.001−4.87−7.31 to −2.430.0002
Unscheduled healthcare utilisation, yes§42 (49.4)109 (55.1)0.80.48 to 1.330.3840.780.43 to 1.410.412
  • * Action plan adherence was defined as the initiation of both prednisone and antibiotics within 3 days of exacerbation onset. All other actions were defined as non-adherence.

  • In the additional definition, adherence was defined as the initiation of prednisone and/or antibiotics within 3 days of exacerbation onset. All other actions were defined as non-adherence.

  • In the worst case analysis, all reported exacerbations were included considering the exacerbations with missing data on the use of antibiotics and/or prednisone as failure to adherence. Adherence was defined as the initiation of prednisone and antibiotics within 3 days of exacerbation onset. Treated recovery time was not calculated as the exacerbations that were added had missing start dates of treatment.

  • § Five exacerbations were excluded due to missing data concerning the use of unscheduled healthcare services.

  • Adjusted for age, sex, post-bronchodilator forced expiratory volume in 1 s as percentage predicted, smoking status, exacerbation severity, contacting the case manager, cardiac disease, use of long-acting bronchodilators and inhaled corticosteroids, influenza vaccination, exacerbation sequence during follow-up and randomisation group in the randomised controlled trial.

  • B, regression coefficient (ie, change in recovery time with adherence).